ZA201204247B - Drug combination with theobromine and its use in therapy - Google Patents
Drug combination with theobromine and its use in therapyInfo
- Publication number
- ZA201204247B ZA201204247B ZA2012/04247A ZA201204247A ZA201204247B ZA 201204247 B ZA201204247 B ZA 201204247B ZA 2012/04247 A ZA2012/04247 A ZA 2012/04247A ZA 201204247 A ZA201204247 A ZA 201204247A ZA 201204247 B ZA201204247 B ZA 201204247B
- Authority
- ZA
- South Africa
- Prior art keywords
- theobromine
- therapy
- drug combination
- drug
- combination
- Prior art date
Links
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 title 2
- 239000000890 drug combination Substances 0.000 title 1
- 229960004559 theobromine Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0919893.8A GB0919893D0 (en) | 2009-11-13 | 2009-11-13 | Drug composition and its use in therapy |
PCT/GB2010/051896 WO2011058374A1 (en) | 2009-11-13 | 2010-11-12 | Drug combination with theobromine and its use in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201204247B true ZA201204247B (en) | 2013-02-27 |
Family
ID=41509327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/04247A ZA201204247B (en) | 2009-11-13 | 2012-06-11 | Drug combination with theobromine and its use in therapy |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP2498776A1 (en) |
JP (2) | JP2013510842A (en) |
CN (1) | CN102740853B (en) |
AU (1) | AU2010317668C1 (en) |
BR (1) | BR112012011224A2 (en) |
CA (1) | CA2780704C (en) |
CO (1) | CO6551745A2 (en) |
EC (2) | ECSP12011893A (en) |
GB (1) | GB0919893D0 (en) |
IL (1) | IL219769A0 (en) |
MX (1) | MX2012005538A (en) |
NZ (1) | NZ599957A (en) |
PE (1) | PE20121472A1 (en) |
PH (1) | PH12012500955A1 (en) |
RU (1) | RU2587329C2 (en) |
SG (1) | SG10201407496SA (en) |
UA (1) | UA105940C2 (en) |
WO (1) | WO2011058374A1 (en) |
ZA (1) | ZA201204247B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3850568D1 (en) * | 1987-10-08 | 1994-08-11 | Andor Bilas | FABRIC MIXTURE TO STABILIZE THE METABOLISM LOCATION. |
WO1995007103A1 (en) * | 1993-09-07 | 1995-03-16 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
HUP9700654A2 (en) | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Antitussive compositions containing theobromine |
US6608073B1 (en) * | 1998-10-14 | 2003-08-19 | New Millennium Pharmaceutical Research, Inc. | Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
HUP9802716A3 (en) * | 1998-11-25 | 2000-08-28 | Chinoin Gyogyszer Es Vegyeszet | Pharmaceutical composition of analgesic activity |
EP1465634B1 (en) * | 2001-12-12 | 2014-10-22 | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services | Methods for using adenosine receptor inhibitors to enhance immune response and inflammation |
BRPI0408059A (en) * | 2003-02-28 | 2006-02-14 | Delex Therapeutics Inc | opioid delivery system |
CN1593451A (en) * | 2003-09-12 | 2005-03-16 | 杨喜鸿 | Externally applied medicine for promoting male erection |
JPWO2006064780A1 (en) * | 2004-12-14 | 2008-06-12 | 塩野義製薬株式会社 | Constipation treatment |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
KR20080009994A (en) * | 2006-07-25 | 2008-01-30 | 안국약품 주식회사 | Cough Treatment Composition |
-
2009
- 2009-11-13 GB GBGB0919893.8A patent/GB0919893D0/en not_active Ceased
-
2010
- 2010-11-12 JP JP2012538416A patent/JP2013510842A/en active Pending
- 2010-11-12 MX MX2012005538A patent/MX2012005538A/en unknown
- 2010-11-12 BR BR112012011224A patent/BR112012011224A2/en not_active IP Right Cessation
- 2010-11-12 EP EP10778715A patent/EP2498776A1/en not_active Ceased
- 2010-11-12 RU RU2012124063/15A patent/RU2587329C2/en not_active IP Right Cessation
- 2010-11-12 WO PCT/GB2010/051896 patent/WO2011058374A1/en active Application Filing
- 2010-11-12 CA CA2780704A patent/CA2780704C/en not_active Expired - Fee Related
- 2010-11-12 NZ NZ599957A patent/NZ599957A/en not_active IP Right Cessation
- 2010-11-12 AU AU2010317668A patent/AU2010317668C1/en not_active Ceased
- 2010-11-12 PE PE2012000650A patent/PE20121472A1/en not_active Application Discontinuation
- 2010-11-12 PH PH1/2012/500955A patent/PH12012500955A1/en unknown
- 2010-11-12 CN CN201080051628.4A patent/CN102740853B/en not_active Expired - Fee Related
- 2010-11-12 UA UAA201207163A patent/UA105940C2/en unknown
- 2010-11-12 SG SG10201407496SA patent/SG10201407496SA/en unknown
-
2012
- 2012-05-11 CO CO12078022A patent/CO6551745A2/en not_active Application Discontinuation
- 2012-05-11 EC ECSP12011893 patent/ECSP12011893A/en unknown
- 2012-05-11 EC ECSP12011892 patent/ECSP12011892A/en unknown
- 2012-05-13 IL IL219769A patent/IL219769A0/en unknown
- 2012-06-11 ZA ZA2012/04247A patent/ZA201204247B/en unknown
-
2015
- 2015-12-04 JP JP2015237086A patent/JP2016041748A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
UA105940C2 (en) | 2014-07-10 |
CO6551745A2 (en) | 2012-10-31 |
GB0919893D0 (en) | 2009-12-30 |
CA2780704C (en) | 2018-07-17 |
IL219769A0 (en) | 2012-07-31 |
RU2012124063A (en) | 2013-12-20 |
PH12012500955A1 (en) | 2013-01-07 |
SG10201407496SA (en) | 2015-02-27 |
JP2013510842A (en) | 2013-03-28 |
BR112012011224A2 (en) | 2017-03-01 |
MX2012005538A (en) | 2012-09-28 |
ECSP12011892A (en) | 2012-09-28 |
RU2587329C2 (en) | 2016-06-20 |
PE20121472A1 (en) | 2012-11-30 |
NZ599957A (en) | 2014-05-30 |
ECSP12011893A (en) | 2012-10-30 |
CN102740853B (en) | 2015-04-08 |
AU2010317668A1 (en) | 2012-06-07 |
WO2011058374A1 (en) | 2011-05-19 |
JP2016041748A (en) | 2016-03-31 |
AU2010317668B2 (en) | 2015-01-22 |
EP2498776A1 (en) | 2012-09-19 |
AU2010317668C1 (en) | 2016-02-11 |
CA2780704A1 (en) | 2011-05-19 |
CN102740853A (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1221478A1 (en) | Sap variants and their use sap | |
IL214244A0 (en) | Scriptaid isosteres and their use in therapy | |
GB0921803D0 (en) | Drug composition and its use in therapy | |
ZA201204248B (en) | Drug combination with theobromine and its use in therapy | |
IL224953A (en) | Theobromine in combination with an expectorant or a mucolytic for use in therapy | |
HK1168283A1 (en) | Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1 | |
ZA201204247B (en) | Drug combination with theobromine and its use in therapy | |
GB201211237D0 (en) | CDK5 inhibitors and therapeutic uses thereof | |
GB2460178B (en) | Depsipeptides and their therapeutic use | |
GB0917533D0 (en) | Azaphthalocyanines and their use in printing | |
HK1160761A1 (en) | Medicament dispenser and its use | |
GB2460181B (en) | Depsipeptides and their therapeutic use | |
GB0921805D0 (en) | Drug composition and its use in therapy | |
GB0910375D0 (en) | Drug composition and its use in therapy | |
GB0905970D0 (en) | Depsipeptides and their therapeutic use | |
GB2460180B (en) | Depsipeptides and their therapeutic use | |
GB0818663D0 (en) | Gene regulation and its use in therapy | |
GB0920267D0 (en) | Drug combination and its use in therapy | |
GB0909352D0 (en) | Drug composition and its use in therapy | |
GB0918728D0 (en) | Drug composition and its use in therapy | |
GB0918727D0 (en) | Drug composition and its use in therapy | |
GB0909354D0 (en) | Drug composition and its use in therapy | |
GB0919890D0 (en) | Drug composition and its use in therapy | |
GB0921804D0 (en) | Drug composition and its use in therapy | |
EP2234667A4 (en) | Therapy calculation and therapy delivery modes |